title: A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements.
authors.affiliation: Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. riessjo@stanford.edu
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Riess
authors.forename: Sukhmani K
authors.initials: SK
authors.lastname: Padda
authors.forename: Charles D
authors.initials: CD
authors.lastname: Bangs
authors.forename: Millie
authors.initials: M
authors.lastname: Das
authors.forename: Joel W
authors.initials: JW
authors.lastname: Neal
authors.forename: Adour R
authors.initials: AR
authors.lastname: Adrouny
authors.forename: Athena
authors.initials: A
authors.lastname: Cherry
authors.forename: Heather A
authors.initials: HA
authors.lastname: Wakelee
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics / Q000401:mortality*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics / Q000401:mortality*; D005260:Female; D015321:Gene Rearrangement; D005971:Glutamates / Q000627:therapeutic use*; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D000068437:Pemetrexed; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D005971:Glutamates; D011518:Proto-Oncogene Proteins; D000068437:Pemetrexed; D006147:Guanine; D011505:Protein-Tyrosine Kinases; C062333:ROS1 protein, human
keywords: Chemotherapy; Molecular subtypes; NSCLC; Pemetrexed; ROS1